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Despite the established contribution of deregulated microRNA (miRNA) function to carcino-
genesis, relatively few miRNA-cancer gene interactions have been validated, making it diffi-
cult to appreciate the true complexity of miRNA-cancer gene regulatory networks.
Results
In this effort, we identify miRNA interactomes of 17 well-established cancer genes, involved
in various cancer types, through a miRNome-wide 3’ UTR reporter screening. Using a novel
and performant strategy for high-throughput screening data analysis, we identify 390 inter-
actions, quadrupling the size of the known miRNA interactome for the cancer genes under
investigation. Clear enrichments of established and predicted interactions underscore the
validity of the interactome data set. Interactomes appear to be primarily driven by canonical
binding site interactions. Nonetheless, non-canonical binding sites, such as offset 6mer and
seed-mismatched or G:U wobble sites, also have regulatory activity, albeit clearly less pro-
nounced. Furthermore, we observe enhanced regulation in the presence of 3’ supplemen-
tary pairing for both canonical and non-canonical binding sites.
Conclusions
Altogether, the cancer gene-miRNA interactome data set represents a unique resource that
will aid in the unraveling of regulatory miRNA networks and the dynamic regulation of key
protein-coding cancer genes. In addition, it uncovers aspects of the functional miRNA bind-
ing site’s architecture and the relative contributions of different binding site types.
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Introduction
In normal cells, the expression of tumor suppressor genes and oncogenes is tightly controlled
by a myriad of cooperative genetic and epigenetic mechanisms to guarantee correct dynamic
gene dosages. Perturbation of these mechanisms can result in aberrant expression and may
contribute to cancer formation. Post-transcriptional regulation by microRNAs (miRNAs) is
one of the best-characterized gene regulatory mechanisms, and deregulated miRNA expres-
sion has been extensively documented in the pathogenesis of various cancer types [1]. While
evidence emerged that miRNAs can work in oncogenic or tumor suppressor cooperative net-
works [2–4], aberrant expression of even a single miRNA can be sufficient to initiate tumor
development [5,6].
miRNAs are small non-coding RNAmolecules with a length of approximately 21 nucleo-
tides. Mature miRNAs are processed from precursor molecules and execute their gene regula-
tory function by guiding an effector complex, the miRNA-induced silencing complex
(miRISC), to binding sites in target mRNAmolecules [7]. Upon binding, miRISC initiates a
sequence of events leading to inhibition of translation and decay of mRNAmolecules, and ulti-
mately to reduced protein levels [8–10].
Complementarity with the miRNA seed region, the sequence spanning nucleotides 2 to 7 of
the 5’ end of the mature miRNA, appears to be the most important determinant of a functional
miRNA binding site in vertebrates (Figure A in S1 Fig) [11–13]. Not surprisingly, the seed-
region is the most evolutionarily conserved region of miRNAs [11,14]. Frequently, 6mer seed-
pairing is augmented with an adenosine at the 3’ end of the site, constituting a 7mer-A1 bind-
ing site. Similar to the seed-match, the presence of adenosines at this position is highly evolu-
tionary conserved [12,15]. Despite clear conservation, sites with a nucleotide match instead
of an adenosine have also occasionally been described to be functional [16]. Alternatively,
6mer seed-pairing can be preceded by an additional nucleotide match at the 5’ end of the site,
constituting a 7mer-m8 binding site. If both the 3’ adenosine and the additional 5’ match are
present, an 8mer binding site is established. On average, 8mer sites are more efficacious than
7mer-m8 sites, which in turn are more efficacious than 7mer-A1 sites and 6mer sites respec-
tively (Figure A in S1 Fig). Sequence complementarity to the 3’ end of the miRNA, or so-called
3’ supplementary binding (Figure B in S1 Fig), has been shown to slightly increase seed-
matched site potency [13,15,17]. Seed-matched miRNA binding sites have typically been con-
sidered as canonical sites, being both more frequently involved in miRNA interactions and
mediating more pronounced regulation compared to other site types. Both statements, how-
ever, are still being debated and contradictory reports exist.
In addition to seed-matched sites, non-canonical binding has been described, but only a
limited number of efforts have delineated well-defined non-canonical binding site patterns.
Offset 6mer sites represent one class of non-canonical sites and display a seed-match with a
single-nucleotide offset (Figure C in S1 Fig) [12,13,16,18,19]. Seed-mismatched sites represent
another type of non-canonical sites and have a single nucleotide mismatch in the seed region
(Figure D in S1 Fig) [20,21], or a G:U wobble [21,22], which is an energetically more favorable
mismatch. The imperfect seed-match of these sites is sometimes compensated by extensive 3’
compensatory pairing (Figure B in S1 Fig), although such sites are rather rare [13,23]. Cen-
tered sites are characterized by at least 11 consecutive nucleotide matches to the central region
of the miRNA (either nucleotides 4–14 or 5–15), without substantial pairing to the 5’ or the 3’
ends of the miRNA [11,24]. G-bulge sites are also seed-mismatched, but a nucleotide is bulged
out in the mRNA in order to match the seed-region (Figure E in S1 Fig) [11,14,25]. Occasion-
ally, miRNA-mRNA interactions with seed-mismatches, but with extensive pairing along the
entire mRNA have been observed [12,15,26,27].
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In general, non-canonical binding sites appear to be less potent than canonical sites,
although there is ongoing debate. Offset 6mer, G-bulge and seed-mismatched or G:U wobble
sites are thought to be either not effective or less effective than 6mer sites [19,20,25]. Centered
sites and 3’ compensatory sites, on the other hand, have clearly been shown to have a regula-
tory effect, but are thought to constitute less than 1% of all targeting [23,24]. Varying numbers
have been reported on the prevalence of non-canonical interactions, ranging from as low as
7% to as high as 88% [20,21,25,28,29]. Hence, further large-scale studies are warranted to
investigate both the prevalence and the potency of non-canonical binding events.
Initially, miRNA binding sites were thought to be exclusively located in the 3’ untranslated
region (UTR) of mRNAmolecules. However, functional miRNA binding sites have occasion-
ally been reported in 5’UTRs [16,30] and, more frequently, within mRNA coding sequences
[17,31,32]. Recently, large-scale mappings of miRNA interactions with AGO CLIP-seq based
methods and AGO CLASH have supported this notion and revealed miRNA binding to the
entire length of mRNAmolecules [13,15,17,28,29]. Notably, Helwak et al. observed the largest
number of miRNA interactions with mRNAs to occur in the coding sequence (61%), followed
by the 3’ UTR (34%) and 5’UTR (5%) [28]. In contrast, Chi et al. observed the majority of miR-
ISC-binding to occur in 3’ UTRs of mRNAs (61%), followed by the coding sequence (38%)
and the 5’UTR (1%) [33]. A recent meta-analysis of 34 AGO CLIP-seq data sets by Clark et al.
confirmed the latter finding [29]. Of note, the relative proportion of binding events in 5’UTRs,
coding sequences, and 3’ UTRs varies between individual miRNAs [28]. Despite ongoing
debate, the regulatory effect of miRNAs is believed to be mainly attributable to 3’ UTR interac-
tions. Interactions outside the 3’ UTR seem to confer little regulatory activity [20,21,34,35] and
potentially mediate more subtle regulation or serve other functions.
Typically, miRNAs have an extensive target repertoire, with estimated averages of 100 to
1000 target sites per miRNA, and with multiple sites often present per mRNA [13,23,29]. In
addition, mRNAs are frequently targeted by more than one miRNA [36]. Up to half of the
human protein-coding genes are believed to be controlled by miRNAs [19]. Nonetheless, only
few miRNA interactions are actually validated, making it difficult to appreciate the true com-
plexity of miRNA regulation. Furthermore, reported interactions are often validations of
model predictions, and are therefore biased towards interactions adhering to the current
(incomplete) rules describing miRNA binding. Hence, important regulatory miRNAs with a
non-canonical mode of interaction are potentially ignored. Knowledge on the full complement
of regulatory miRNAs is imperative to understand the dynamic regulation and potential
deregulation of genes in disease and development.
Here, we identify the miRNA interactomes of a set of 17 established cancer genes, involved
in various cancer types. Applying an unbiased, miRNome-wide 3’ UTR reporter screening, we
identify 390 interactions, quadrupling the available knowledge on miRNA regulation for these
genes. We show that miRNA interactomes appear to be primarily driven by canonical binding
site interactions. However, non-canonical binding sites also confer regulation, albeit clearly
less pronounced. Furthermore, enhanced regulatory activity upon 3’ supplementary binding is
present for both canonical and non-canonical binding sites.
Results
miRNA interactomes were inferred for 17 genes with known pan-cancer involvement or an
established role in cancer types such as breast cancer, lung cancer, colon cancer, T-cell acute
lymphoblastic leukemia (T-ALL) and neuroblastoma (Fig 1A). The cancer gene selection is
supported by information from the Cancer Gene Census (cancer.sanger.ac.uk/cancergenome/
projects/census/) and selected publications (see S1 Table for PubMed IDs).
MicroRNA interactomes of cancer genes
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Interactions between all miRNAs annotated in miRBase 9.2 and the 3’ UTRs of the selected
genes were probed in independently replicated reporter gene screenings. In brief, HEK293T
cells were co-transfected with 3’ UTR luciferase reporter constructs and a library of 470
miRNAmimics, in total probing 7990 interactions. Forty-eight hours after co-transfection,
reporter gene activities were assessed to score potential down-regulation as a result of miRNA-
3’ UTR interaction. Reporter gene activities were converted into interaction scores to eliminate
miRNA-treatment-specific bias. An interaction score threshold was then applied in order to
label interactions.
A novel metric for the scoring of high-throughput screening data
Interactions between miRNAs and 3’ UTRs were evaluated calculating the interaction score, a
novel metric for the analysis of high-throughput screening data. Analysis of reporter gene
activities with classic z-score calculation revealed a miRNA-specific bias in screening results,
with unequal distributions of z-scores for different miRNAs (S2 Fig). Under the assumption
Fig 1. Cancer gene-miRNA interactomes. (A) Selection of 17 cancer genes involved in multiple cancer types. For each gene the number of interactions
identified in the 3’ UTR reporter screening is listed. (B)Overview of 3’ UTR reporter screening results. Average interaction scores for all probed
miRNA-3’ UTR combinations. (C) The miRNA interactome of TP53. (D) The miRNA interactome of MYCN.
https://doi.org/10.1371/journal.pone.0194017.g001
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that none of the tested miRNAs systematically targets a substantial part of all genes investi-
gated, the interaction score eliminates the systematic bias through median centering of
miRNA-specific z-score distributions. The interaction score is more negative for miRNAs that
interact with the 3’ UTR.
In this data set, the interaction score outperforms commonly used metrics for high-
throughput screening data analysis, such as z-scores, B-scores and knockdown percentages.
This is apparent from ROC-curve analysis, using a set of previously reported interactions pres-
ent in our screening as positive controls, and a set of interaction scores from an empty 3’ UTR
reporter screening as negative controls (Fig 2A). Areas under the ROC-curve (AUC) are signif-
icantly different for the different metrics (p< 0.05), with the interaction score having the best
overall performance (AUC = 0.822). The point of highest accuracy in this ROC-curve (interac-
tion score = -1.94; accuracy = 91%) was put forward as the interaction score cutoff to separate
positive from negative interactions, and corresponds to a precision of 88%, a specificity of 99%
and a sensitivity of 51%, hereby favoring false negative over false positive interactions.
High technical and biological reproducibility of 3’ UTR reporter screenings
For each gene, either duplicate (ALK, BRCA1, BRCA2, EZH2, FBXW7, HRAS, MYB, MYC,
MYCN, MYT1L, NOTCH1, PALB2, PHOX2B, RB1 and ZEB2) or triplicate (PHF6 and TP53)
3’ UTR reporter screenings were performed. Reproducibility of replicated screenings was high,
as can be appreciated from the correlation in interaction scores (Pearson correlation = 0.662,
p< 0.05) (Fig 3A and 3B). Further underscoring this reproducibility is the observation that
similar miRNA sequences display similar regulatory behavior, as apparent from the clustering
of miRNA family members according to their activity in the screening (Fig 3C). Prominent
Fig 2. Interaction score performance. (A) ROC-curve analysis of different metrics for high-throughput screening
data-analysis on a set of positive and negative controls in the 3’ UTR reporter screening. Interaction scores and z-scores
are calculated as described in the Methods section. B-scores are obtained by applying Tukey median polish to z-scores,
in order to remove plate positional bias. Knockdowns are calculated by expressing normalized reporter activities
(NRAs) relative to the average NRA of four non-targeting miRNA treated controls in the same assay plate. (B)
Distributions of average interaction scores for positive and negative controls are clearly distinct. Application of the
interaction score cutoff retrieves positive controls with 51% sensitivity, whereas negative controls are correctly called
with a specificity of 99%. Precision obtained with this cutoff (i.e. the proportion of identified interactions that are true
interactions) is 88%. Reprinted from Van Peer et al. [37] under a CC-BY 4.0 license, with permission from Oxford
University Press, original copyright 2016.
https://doi.org/10.1371/journal.pone.0194017.g002
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Fig 3. 3’ UTR reporter screening reproducibility. (A) Correlation of interaction scores from replicate 3’ UTR reporter screenings. (B) Correlation of
interaction scores with a density profile, showing that the largest fraction of interaction scores is centered around 0. (C)Hierarchical clustering of
miRNAs according to their activity in the 3’ UTR reporter screening. For each miRNA pair, the Pearson correlation between average interaction scores
for all 17 cancer genes was calculated. Correlation vectors for all miRNAs are subsequently clustered using Euclidean distance as the distance measure.
Members of the same miRNA family, in addition to families with identical or similar seed-sequences, cluster together. For the let-7 family, 9 out of 9
members cluster together. The mir-34 (2 out of 3 members) and the mir-449 family (2 out of 2 members) also cluster together. The only member not
clustering (hsa-miR-34b) is the only one having a different, 1-nucleotide offset seed sequence. The mir-302 (4 out of 5 members) and mir-515 family (6
out of 32 members) cluster together with miRNAs with identical or 1-nucleotide offset seed sequences (red underline) such as hsa-miR-20b, hsa-miR-
512-3p, hsa-miR-372, hsa-miR-373 and hsa-miR-17-5p. The mir-130 family (3 out of 3 members) clusters together with hsa-miR-454-3p that has an
identical seed sequence (brown underline).
https://doi.org/10.1371/journal.pone.0194017.g003
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examples are the let-7 family (miRNA family ID: MIPF0000002) and the mir-130 family
(MIPF0000034), of which respectively all nine and all three mature miRNAs annotated in
miRBase 9.2 cluster together. Furthermore, different miRNA families with identical seed
sequence, such as the mir-34 (MIPF0000039) and the mir-449 family (MIPF0000039), or the
mir-302 (MIPF0000071) and mir-515 family (MIPF0000020), also cluster together.
Enrichment of predicted and established interactions
Predicted miRNA-3’ UTR interactions have significantly more negative interaction scores in
our data set. Moreover, score distributions gradually shift towards more negative values as
more models predict the interactions (Fig 4A, p< 0.01). Combining the output of multiple
models has been questioned in the past [38], but seems to be able to increase the precision of
prediction (also referred to as the positive predictive value) in our data set (precision = 39% for
predictions by at least five models). While all tested models (TargetScan, Mirtarget2, PITA,
RNA22, miRanda and DIANA-microT-CDS) yielded interaction score distributions that were
significantly shifted towards more negative scores, it is clear that different models have differ-
ent performances, with MirTarget2 having the highest precision (37%) and the most pro-
nounced shift (Fig 4B). Similar to predicted interactions, previously established interactions
(see ‘Interaction score calculation’ in Methods section for details) also have significantly more
negative interaction scores (Fig 4C, p< 0.001), further underscoring the validity of our data
set.
Identification of cancer gene miRNA interactomes
Applying the highly specific and precise interaction score cutoff, we identified miRNA interac-
tomes of 17 selected cancer genes. A total of 390 interactions was identified, of which 344 are
novel (Fig 1B). Notably, 83 of the identified interactions (21%) lack a seed-match and are
therefore not detected by most target prediction models, emphasizing the power of an
Fig 4. Predicted and established interactions. Cumulative distributions of average interaction scores for all 7990 miRNA-3’ UTR
combinations probed. (A) according to the number of models that predict them as true interactions. Interaction scores are clearly lower for
combinations that are predicted by more models. All distributions are significantly different from one another (one-sided Kolmogorov-
Smirnov p-values< 0.01 after Benjamini-Hochberg multiple testing correction). (B) according to prediction by individual models.
MirTarget2 predictions have the lowest scores. For each model, the distribution of interaction scores for predicted interactions is
significantly different from that of non-predicted interactions (one-sided Kolmogorov-Smirnov p-values< 0.01 after Benjamini-Hochberg
multiple testing correction). (C) according to whether they have previously been established as true interactions or not. Previously
established interactions clearly have lower interaction scores. Distributions are significantly different (one-sided Kolmogorov-Smirnov p-
value< 0.001).
https://doi.org/10.1371/journal.pone.0194017.g004
MicroRNA interactomes of cancer genes
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unbiased approach. A comprehensive overview of screening results and the miRNA interac-
tomes of individual cancer genes are presented in S2 Table and S3 Fig. As representative exam-
ples, we focus on the interactomes of TP53 and MYCN, respectively the best-established
tumor suppressor gene and one of the few genes included in our screening effort with a sub-
stantial number of previously established miRNA interactions. For TP53, we identified five
interactions of which two were previously reported (Fig 1C). Nine previously reported interac-
tions could not be confirmed in our screening, which may be due to the nature of the interac-
tion score cutoff, favoring false negatives over false positives. Another possible explanation is
that this may partly represent a positive publication bias for the most widely studied cancer
gene. For MYCN, we could confirm all 11 previously reported interactions and in addition
identified 18 novel interactions (Fig 1D). For four out of five randomly selected, novel interac-
tions with MYCN, we were able to abrogate regulation upon mutation of canonical binding
site patterns in two independently replicated experiments (Fig 5A). Similarly, for four out of
five genes (MYCN, NOTCH1, PHF6, MYC) regulation by hsa-miR-449 could be abrogated in
two independently replicated experiments (Fig 5B).
Regulation of endogenous mRNA levels
In order to validate the interactome data set, we used RT-qPCR to measure endogenous
mRNA levels for the 17 target genes fourty-eight hours after modulation with 470 miRNA
mimics. While an RT-qPCR readout has the advantage of probing endogenous transcript lev-
els, it will not detect any effects resulting from translational inhibition. Nonetheless, we
observed significantly lower expression of endogenous mRNAs for the 390 interactions identi-
fied in the 3’ UTR reporter screening, than for the 7600 miRNA-3’ UTR combinations for
which no interaction was found (Fig 6, p< 0.001).
Canonical binding site potency
miRNA-3’ UTR combinations with canonical binding sites (2456 combinations with 3730
sites) have significantly more negative interaction scores than combinations without (Fig 7A,
p< 0.001). In addition, combinations with multiple canonical sites (818 combinations)
have more negative scores as compared to combinations with only a single canonical site
(p< 0.001). Furthermore, the hierarchy in potency of the different canonical binding sites is
reflected in the data, with 8mer sites (263 combinations with 298 sites) being the most potent,
followed by 7mer-m8 (665 combinations with 746 sites), 7mer-A1 (699 combinations with 802
sites) and 6mer sites (1473 combinations with 1884 sites) (Fig 7B, p< 0.01 for each compari-
son). Remarkably, merely looking at the presence of multiple 8mer sites (26 combinations)
predicts negative interaction scores with higher precision (77%) than any of the prediction
models considered or combination thereof. In the presence of 3’ supplementary pairing, the
distribution of scores for combinations with canonical binding sites (488 combinations with
531 sites) shifts towards more negative values, confirming that 3’ supplementary pairing
increases canonical binding site potency (Fig 7C, p< 0.001).
Non-canonical binding site potency
The contradictory evidence regarding the regulatory potential of non-canonical binding sites
prompted us to evaluate them in our interactome data set. For offset 6mer sites (1863 combi-
nations with 2514 sites), we observe a clear regulatory effect, with a significant shift in the dis-
tribution of interaction scores (Fig 8A, p< 0.001). Seed-mismatched or G:U wobble sites
(7466 combinations with 55975 sites) also have regulatory potential, although the shift in dis-
tribution is clearly less pronounced (Fig 8B, p< 0.01). Furthermore, no significant differences
MicroRNA interactomes of cancer genes
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Fig 5. 3’ UTR reporter rescue experiment. Rescue of 3’ UTR reporter regulation. (A) For four MYCN interactions significant down-
regulation of reporter activity after miRNA expression modulation can no longer be demonstrated upon canonical binding site mutation
(one-sided t-test; p< 0.001 ⇤⇤⇤; p< 0.01 ⇤⇤; wt = wild-type 3’ UTR; mut = mutant 3’ UTR) in two independently replicated reporter
experiments. Reporter activity is expressed relative to non-targeting miRNA treated controls (NTC). Error bars represent standard
deviations on three technical replicates. Successful rescue of MYCN regulation could only be achieved in one experiment for hsa-miR-494.
MicroRNA interactomes of cancer genes
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(B) For four hsa-miR-449 interactions significant down-regulation of reporter activity after miRNA expression modulation can no longer
be demonstrated upon canonical binding site mutation (one-sided t-test; p< 0.001 ⇤⇤⇤; p< 0.01 ⇤⇤; wt = wild-type 3’ UTR; mut = mutant
3’ UTR) in two independently replicated reporter experiments. Reporter activity is expressed relative to non-targeting miRNA treated
controls (NTC). Error bars represent standard deviations on three technical replicates. Successful rescue of regulation by hsa-miR-449
could only be achieved in one experiment for MYB.
https://doi.org/10.1371/journal.pone.0194017.g005
Fig 6. Endogenous mRNA levels. Cumulative distributions of log2 relative expression levels of endogenous mRNAs measured with RT-qPCR after
miRNAmodulation. The distribution for interactions identified in the 3’ UTR reporter screening is significantly lower than that for miRNA-3’ UTR
combinations for which no interaction was observed (one-sided Kolmogorov-Smirnov p-value< 0.001).
https://doi.org/10.1371/journal.pone.0194017.g006
MicroRNA interactomes of cancer genes
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in distribution could be observed for sites with the G:U wobble or mismatch at a particular
position in the seed region, suggesting that no preferential position exists (data not shown;
Kolmogorov-Smirnov p-values> 0.05 after Benjamini-Hochberg multiple testing correction).
Also, no difference between a G:U wobble, which is an energetically more favorable mismatch,
and other mismatches could be observed (data not shown; Kolmogorov-Smirnov p-values>
0.05 after Benjamini-Hochberg multiple testing correction). G-bulge sites (170 combinations
with 177 sites) don’t appear to have any regulatory potential in this data set and the score dis-
tribution of miRNA-3’ UTR combinations with G-bulge sites is not different from combina-
tions without G-bulge patterns (Fig 8C, p> 0.05). Centered sites were too low in abundance
(6 combinations with 6 sites) to have enough statistical power to detect subtle regulatory
activity.
Similar to canonical binding sites, non-canonical binding sites seem to be more potent in
the presence of additional binding to the 3’ end of the miRNA. For offset 6mer sites, the addi-
tional effect is significant, with a pronounced shift in the distribution of interaction scores
(266 combinations with 275 sites) (Fig 8D, p< 0.001). For seed-mismatched or G:U wobble
sites, the added effect of 3’ supplementary binding is significant but small and therefore prob-
ably biologically less relevant (3973 combinations with 7608 sites) (Fig 8E, p< 0.05). For
seed-mismatched or G:U wobble sites, 3’ compensatory binding has been described as a
more extensive form of 3’ supplementary binding, compensating the incomplete seed-match.
In this data set, however, the effect of 3’ compensation and 3’ supplementation could not be
distinguished (data not shown; Kolmogorov-Smirnov p-value> 0.05). G-bulge sites at last,
although having no apparent effect in the absence of 3’ supplementary pairing, seemed to
have modest regulatory activity in its presence (26 combinations with 27 sites) (Fig 8F,
p< 0.05).
Fig 7. Canonical binding site potency. Cumulative distributions of average interaction scores for all 7990 miRNA-3’ UTR combinations
probed. (A) according to the presence of canonical binding site patterns. Combinations with multiple canonical binding site patterns have
lower interaction scores than combinations with a single pattern, that in their turn have lower scores than combinations without canonical
binding site patterns. All distributions are significantly different from one another (one-sided Kolmogorov-Smirnov p-values< 0.001 after
Benjamini-Hochberg multiple testing correction). (B) according to the presence of different types of canonical binding site patterns.
Combinations with at least one 8mer pattern, have lower interaction scores than combinations with at least one 7mer-m8, one 7mer-A1
and one 6mer pattern, respectively (combinations with multiple types of binding site patterns are considered in all respective distributions).
Notably, the presence of multiple 8mer patterns produces the largest shift in distribution. All distributions are significantly different from
one another (one-sided Kolmogorov-Smirnov p-values< 0.01 after Benjamini-Hochberg multiple testing correction). (C) according to the
presence of 3’ supplementary pairing. Combinations harboring canonical binding site patterns with 3’ supplementary pairing have lower
interaction scores than those without. All distributions are significantly different from one another (one-sided Kolmogorov-Smirnov p-
values< 0.001 after Benjamini-Hochberg multiple testing correction).
https://doi.org/10.1371/journal.pone.0194017.g007
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Discussion
We defined miRNA interactomes of 17 cancer genes involved in multiple cancer entities,
based on an unbiased 3’ UTR reporter screening of unprecedented scale, probing 470 miR-
NAs. With 390 interactions identified (of which 344 novel) and 92 a priori known interactions,
we quadrupled the size of the known miRNA interactome for these genes. To analyze the
screening results, we developed a novel metric, the interaction score, that outperforms com-
monly used metrics for high-throughput screening data analysis. By favoring false negative
over false positive interactions, high-confidence interactomes are produced. Compared to
Fig 8. Non-canonical binding site potency. Cumulative distributions of average interaction scores for all 7990 miRNA-3’ UTR
combinations probed. (A) according to the presence of offset 6mer binding site patterns. Combinations with at least one offset 6mer
pattern, have lower interaction scores than combinations without. Distributions are significantly different (one-sided Kolmogorov-
Smirnov p-value< 0.001). (B) according to the presence of seed-mismatched or G:U wobble binding site patterns. Combinations with at
least one seed-mismatched or G:U wobble pattern have lower interaction scores than combinations without. Distributions are
significantly different (one-sided Kolmogorov-Smirnov p-value< 0.01). (C) according to the presence of G-bulge binding site patterns.
Combinations with G-bulge patterns don’t have detectably lower interaction scores than combinations without. Distributions are not
significantly different (one-sided Kolmogorov-Smirnov p-value> 0.05). (D) according to the presence of offset 6mer binding site
patterns with 3’ supplementary pairing. Combinations harboring offset 6mer patterns with 3’ supplementary pairing have lower
interaction scores than those without. All distributions are significantly different from one another (one-sided Kolmogorov-Smirnov p-
values< 0.001 after Benjamini-Hochberg multiple testing correction). (E) according to the presence of seed-mismatched or G:U wobble
binding site patterns with 3’ supplementary pairing. Combinations harboring seed-mismatched or G:U wobble patterns with 3’
supplementary pairing have lower interaction scores than those without. All distributions are significantly different from one another
(one-sided Kolmogorov-Smirnov p-values< 0.05 after Benjamini-Hochberg multiple testing correction). (F) according to the presence of
G-bulge binding site patterns with 3’ supplementary pairing. Combinations harboring G-bulge patterns with 3’ supplementary pairing
have lower interaction scores than those without. All distributions are significantly different from one another (one-sided Kolmogorov-
Smirnov p-values< 0.05 after Benjamini-Hochberg multiple testing correction).
https://doi.org/10.1371/journal.pone.0194017.g008
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similar, smaller-scale efforts [2,39], our screening is not biased by upfront target prediction
that often limits the focus to canonical binding events. The power of this unbiased approach is
apparent from the fact that 21% of the identified interactions do not have a seed-match,
although it can’t be ruled out that this fraction is enriched for screening false positives.
The validity of our approach is illustrated by numerous observations, such as the high tech-
nical and biological reproducibility. Furthermore, interactions identified are strongly enriched
for previously established as well as predicted interactions. The successful abrogation of regula-
tion for selected interactions upon binding site mutation further underscores the quality of the
interactomes. In general, regulatory miRNAs identified also induce higher down-regulation of
endogenous mRNA levels, confirming that reporter gene results can be recapitulated on native
transcripts. Moreover, it suggests that regulation at least in part occurs through the induction
of mRNA decay, which is in line with published mechanistic models of miRISC effector func-
tion [8–10].
In contrast with AGO CLIP-seq and AGO-CLASH data sets, the interactome data set cap-
tures the regulatory effect of miRNAs, enabling the study of binding site potency. Interestingly,
we found that miRNA interactomes identified here appear to be primarily driven by canonical
binding site interactions. While non-canonical offset 6mer, and seed-mismatched or G:U wob-
ble sites also confer regulatory activity, it is clearly less pronounced. Of note, this data set does
not hold information on the occurrence and position of miRISC binding events. Hence, no
distinction can be made between non-functional and functional binding sites that interact
with miRISC. Therefore, the presence of non-functional sites potentially causes us to underes-
timate the potency of the functional fraction, as we consider them in the same analyses. Func-
tional binding sites have gone through a process of evolutionary selection and potentially
require additional unknown sequential or non-sequential features. Each nucleotide pattern,
however, also has a baseline prevalence in the genome, without any evolutionary constraint
necessarily being involved. The underestimation of potency is therefore expected to be more
pronounced for shorter binding site patterns with a higher baseline prevalence, such as non-
canonical offset 6mer, seed-mismatched or G:U wobble sites. This objection aside, it has been
described that non-canonical sites confer less regulatory activity [19,20,25], and in this respect
our data confirms current views. Their more subtle effects might be evolutionary selected to
enable expression fine-tuning or they might represent weaker evolutionary intermediates of
canonical binding sites. Alternatively, such sites might serve other functions than expression
regulation, such as sponge-like miRNA sequestration by the target [40–42]. Correspondingly,
the observed hierarchy of canonical binding sites, with increasing potency with pattern length,
might in theory also be due to a higher baseline prevalence for 6mer sites, compared to 7mer
and 8mer sites, respectively. However, this hierarchy has previously been well-established [15].
A similar reasoning applies to the observed increased regulatory potential in the presence of
multiple canonical binding sites, that might reflect a higher chance on the presence of at least
one functional site or, alternatively, be a consequence of additive and cooperative interactions
between multiple sites, as previously shown to occur [15,43,44].
Nevertheless, even despite potential underestimation of the extent of their effect, our obser-
vations confirm that both canonical and non-canonical sites can confer regulatory activity and
reduce protein levels. Furthermore, this regulatory activity is clearly enhanced in the presence
of additional base pairing with the 3’ end of the miRNA. For canonical and offset 6mer sites
this additional effect is pronounced, whereas for G-bulge and seed-mismatched or G:U wobble
sites it is moderate. Although demonstrated for canonical [15] and seed-mismatched or G:U
wobble sites [13,23], for offset 6mer and G-bulge sites we show this for the first time here.
Moreover, G-bulge sites even only seem to have regulatory activity in the presence of 3’ supple-
mentary binding and are inert in its absence. G-bulge sites were initially described for mmu-
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miR-124 in mice brain, but have not been described as a general mode of miRNA interaction.
Recent data indeed suggest that the mode of interaction is highly miRNA-dependent, with
different miRNAs preferring different binding site types [28]. It is therefore possible that G-
bulge interactions are restricted to a limited subset of miRNAs. Given the limited number of
mRNAs considered, functional G-bulge interactions are therefore potentially underrepre-
sented in our data set, precluding robust assessment of their potency. Nonetheless, the regula-
tory effect upon 3’ supplementary pairing can be demonstrated.
The miRNA interactome data set represents an interesting opportunity for improving
miRNA target prediction. Data sets that have typically been used for training prediction mod-
els include microarray and SILAC mass spectrometry gene expression measurements after
miRNAmodulation, as well as AGO HITS-CLIP data. Typically, in these data sets the effects
of only one or a couple of miRNAs on a large number of genes are probed. Therefore, resulting
models are biased towards a very limited number of miRNAs, making it more difficult to gen-
eralize their predictions. Indeed, it has been shown that the mode of interaction can be very
miRNA-dependent, with different miRNAs interacting with different binding site types [28].
The miRNA interactome data set, on the other hand, includes interaction information for 470
miRNAs and a limited number of genes. It therefore forms a unique and complementary alter-
native to currently available data sets. The miRNA interactome data set has already been used
as a training data set for building the miSTAR model [37]. This model was trained without
considering the non-canonical binding site information in the data set, leaving large potential
still unexploited. Nonetheless, the miSTAR model already outperforms published and widely
used models, underscoring the quality and the value of the miRNA interactome data set pre-
sented here.
Conclusions
In conclusion, we generated miRNA interactomes for a selection of prominent and widely
studied cancer genes by application of a high-throughput reporter screening and introduced a
new and simple method for analysis of high-throughput screening data, aimed at eliminating
treatment-specific bias.
With this unprecedented and unbiased effort, we realize a four-fold increase in knowledge
on regulatory miRNAs for the genes under investigation. This rich and unique resource of
interactions will further help unraveling the regulatory networks and dynamic regulation of
cancer genes in multiple cancer entities. Notably, the interactome data set provides further
insight in the architecture of the effective miRNA interaction and shows the regulatory poten-
tial of both canonical and non-canonical binding sites, with the latter being clearly less potent.
In addition, it reveals enhanced regulatory activity of both canonical and non-canonical bind-
ing sites with 3’ supplementary pairing.
Materials & methods
3’ UTR reporter screening
HEK293T cells were obtained from the American Type Culture Collection (ATCC). Cells
were seeded (10,000 cells/well) in opaque 96-well plates in 80 μl RPMI-1640 supplemented
with fetal calf serum (FCS) (10%), L-Glutamine (2 mM), and HEPES (25 mM). MicroClime
Environmental Lids (Labcyte) filled with 2.5 ml H2O were used to minimize edge effects on
assay results, due to greater evaporation in edge wells of assay plates. Cells were grown at
>90% H2O saturation and 5% CO2. Twenty-four hours after seeding, cells were co-trans-
fected with 100 ng of a 3’ UTR reporter construct, 20 ng of a control reporter construct and
2.5 pmol of miRNA mimic from a library containing all human mature miRNAs (470)
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catalogued in release 9.2 of miRBase except for hsa-miR-122a (Ambion’s Pre-miR miRNA
Precursor Library—Human V3). Mature miRNA sequences and accession numbers of the
mimics are listed in S1 File. Four non-targeting miRNA treated controls (Ambion’s Pre-miR
Negative Control #2—AM17111) and four vehicule treated controls were included in each
culture assay plate. The 3’ UTR reporter construct is a modified version of the pGL4.11
[luc2P] vector (Promega) and contains a multiple cloning site (MCS) upstream of the firefly
(Photinus pyralis) luciferase gene (luc2P) that harbors an hPEST protein destabilization
sequence. A constitutive RPL10 promotor was cloned in the MCS, and an additional MCS
(with XbaI, NheI, AvrII, EcoRV, XhoI and FseI restriction sites) was inserted downstream of
the luc2P gene to enable cloning of 3’ UTR sequences. A reporter construct sequence map is
provided in S2 File. Human 3’ UTR insert sequences for 17 selected cancer genes are listed
in S3 File. As control reporter construct, the pRL-TK vector (Promega) was used, containing
a non-regulable sea pansy (Renilla reniformis) luciferase gene (Rluc). Lipid-based co-trans-
fections were performed using 0.4 μl of DharmaFECT Duo transfection reagent (Dharma-
con). Transfection mixes with a total volume of 10 μl were incubated for 30 minutes after
reconstitution, subsequently diluted two-fold in RPMI-1640, and finally added to cells for a
total culture volume of 100 μl. Liquid handling for co-transfection was done using an EVO
100 pipetting robot (Tecan).
Forty-eight hours post-transfection, luc2P and Rluc reporter gene activities were assayed
using the Dual-Luciferase Assay System (Promega) according to the manufacturer’s protocol
with minor adjustments (LARII and Stop & Glo buffer volumes were reduced to 50 μl). Lumi-
nescence values were measured using a FLUOstar OPTIMAmicroplate reader (BMG LAB-
TECH). A reporter screening spans six 96-well assay plates per gene (and a single gene is
assayed per assay plate). Reporter screens were replicated in at least two independent experi-
ments for each gene.
Interaction score calculation
Cancer gene 3’ UTR reporter (luc2P) activities were normalized to control reporter (Rluc)
activities. Normalized reporter activities (NRA) were log2-transformed to obtain a symmetrical
distribution and expressed as robust z-scores (z), calculated per assay plate, in order to exclude
plate-specific bias and compare the results from different assay plates. Robust z-scores were
corrected for treatment-specific systematic effects by median centering z-score distributions
on a per miRNA basis (S2 Fig). The resulting metric is termed an interaction score (i), and is
more negative for miRNAs that interact with the 3’ UTR. Interaction scores from replicated
screening s are averaged.
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with m = miRNA; g = gene; r = screening replicate; t = total number of screening replicates for
gene g; p = assay plate in which the combination of miRNA m and gene g is probed in screen-
ing replicate r (all combinations probed within the same assay plate p involve the same gene
g); MAD =median absolute deviation.
In order to establish an interaction score cutoff that discriminates between true positive
and true negative interactions with optimal precision, sensitivity and specificity, ROC-curve
analysis was performed (Fig 2A). To this purpose, a set of validated interactions was obtained
by curating literature, using an automated text-mining approach similar to the one used for
the creation of the PubMeth database [45]. Briefly, NCBI’s PubMed database was queried on
December 18, 2012 with the names of all miRNAs in the mimic library, their aliases and tex-
tual variants (frommiRBase and GeneCards), in combination with all aliases and textual vari-
ants of the genes under investigation (from GeneCards). PubMed records were subjected to
expert revision, with the criterion for inclusion as a true interaction being a successful 3’
UTR reporter assay in which the complete or partial human 3’ UTR sequence was cloned,
complemented with a rescue of reporter regulation upon binding site mutation or deletion,
or alternatively, omission of the complete 3’ UTR. A total of 92 validated interactions was
retrieved for the 17 cancer genes under investigation. An overview of PubMed IDs for publi-
cations reporting on these interactions is given in S3 Table. Validated negative interactions
are generally not published. As an alternative, a set of interaction scores was generated by
duplicate screening of the miRNA library on a reporter gene construct that contained no 3’
UTR.
Site-directed mutagenesis of reporter constructs
Mutagenesis of 3’ UTR reporter constructs was carried out using the QuikChange II Site
Directed Mutagenesis Kit (Stratagene), according to manufacturer instructions (with 30 ng
reporter construct input in a 12-cycle PCR reaction). Putative canonical binding sites for 10
selected interactions were mutated, altering nucleotides across positions 3, 4, 5 and 7 of the
miRNA’s 5’ end for 6mer and 7mer-A1 sites, and nucleotides across positions 4, 5, 6 and 8 for
7mer-m8 and 8mer sites. More specifically, mutations of A to C, G to T, C to A and U to G
were introduced. Mutagenesis primers are listed in S4 Table.
RT-qPCR screening
HEK293T cells were seeded as described for the 3’ UTR reporter screening. Twenty-four
hours after seeding, cells were transfected with 2.5 pmol of miRNAmimics from a miRBase
9.2 library, as described for the reporter screening, but excluding reporter constructs, and
using the DharmaFECT2 transfection reagent (Dharmacon). Four non-targeting miRNA
treated controls (Ambion’s Pre-miR Negative Control #2—AM17111) and four vehicule
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treated controls were included in each culture assay plate. Transfections were replicated in two
independent experiments.
In order to prepare cDNA frommore than 1000 cell culture samples, an approach that we
previously validated and in which cDNA synthesis is carried out on crude cell lysates instead
of on purified RNA samples was followed [46]. Forty-eight hours after cell seeding, cell cul-
tures were lysed and lysates were DNase and proteinase K treated using the SingleShot Cell
Lysis Kit (Bio-Rad), according to the manufacturer’s protocol. Subsequently, cDNA was pre-
pared from 4 μl unpurified cell lysate using the iScript cDNA synthesis kit (Bio-Rad), accord-
ing to the manufacturer’s protocol.
qPCR gene expression quantifications were performed and reported according MIQE
guidelines (Minimum Information for Publication of Quantitative Real-Time PCR Experi-
ments) [47]. Reactions contained 2.5 μl Sso Advanced SYBR mix (Bio-Rad), 1.25 pmol of both
forward and reverse primer, and 2 μl of 4x diluted cDNA sample, for a total volume of 5 μl.
Thermal cycling conditions were as follows: 95˚C for 2 min, followed by 44 cycles of 95˚C for
5 sec, 60˚C for 30 sec, and 72˚C for 1 sec. Melting curve analysis was performed with the fol-
lowing cycling conditions: 95˚C for 5 sec, 60˚C for 1 min, gradual heating to 95˚C at a ramp-
rate of 0.11˚C/sec, and cooling to 37˚C for 3 min. Single replicate reactions were performed in
384-well plates using a CFX384 instrument (Bio-Rad). Liquid handling was done using an
EVO 100 pipetting robot (Tecan). All qPCR assays were designed and validated in silico using
the primerXL evaluation pipeline [48] and empirically validated, checking both primer effi-
ciency and specificity. Primer sequences are provided in S5 Table, together with information
on which transcript isoforms are detected.
Expression levels were normalized, inter-run calibrated, calculated relative to the average
expression level in all samples and log2-transformed. All calculations were done using the
qbase+ software version 2.6 (Biogazelle) [49]. Normalization was performed using four stably
expressed reference genes (HPRT1, TBP, UBC and YWHAZ) validated using the geNorm [50]
module in qbase+. Inter-run calibration was performed using four calibrator samples included
in quadruplicate reactions in each RT-qPCR assay plate. Calibrator samples comprised the
MicroArray Quality Control RNA sample A (MAQCA) [51], and a sample consisting of equal
mass equivalents of MAQCA RNA, pooled RNA from a neuroblastoma cell line panel (IMR-
32, NGP, SK-N-AS, SK-N-SH), and from a T-ALL cell line panel (Jurkat, LOUCY, HPB-ALL,
ALL-SIL). Both samples were used in two concentrations with a two-fold difference (2.5 ng
and 5 ng cDNA input in qPCR reactions).
miRNA interaction prediction
Six different models were used to predict miRNA-3’ UTR interactions in the interactome data
set: TargetScan (version 6.2) [15,52], miRanda (August 2010 version) [52], MirTarget2 [53],
RNA22 (version 1) [54], PITA [55] and DIANA-microT-CDS [32]. Custom predictions (i.e.
for the specific miRNA mimic sequences and 3’ UTR reporter vector insert sequences) were
performed either online (TargetScan, RNA22), by executing the source code (miRanda, PITA)
or offline by the authors from the original paper (MirTarget2, DIANA-microT-CDS).
Although most models produce continuous prediction scores, this continuous information
was not taken into account. Instead, each miRNA-3’ UTR combination was labeled as either
predicted or not predicted to interact by applying the default prediction score cutoff (if any)
used by the respective online web tools. In other words, combinations returned by the web
tool—or would have been in case of offline prediction—are considered as predicted interac-
tions. An overview of predictions is presented in S6 Table.
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Data mining and statistics
All statistical analyses and data processing steps, including interaction score calculation, were
performed using the R statistical programming environment (version 3.0.2).
miRNA nomenclature and annotation
In this study, we consider miRNA sequences (and miRNA families) annotated in release 9.2 of
the miRBase database. Accordingly, we use nomenclature of this release to report and discuss
the results. However, when referring to other studies in the discussion, we use the nomencla-
ture applied in these studies. In order to facilitate comparison and integration of the data pre-
sented here with other studies, we refer to miRBase Tracker (www.mirbasetracker.org), an in-
house developed web tool for miRNA reannotation that enables straightforward assessment of
annotation changes between releases [56]. Of note, the most recent miRBase release at time of
publication (release 21, June 2014) contains 2588 human mature miRNAs. Compared to miR-
Base release 9.2, 2124 mature miRNAs are newly annotated, whereas 7 are deleted. A total of
159 miRNAs have an altered canonical sequence and 322 have undergone a name change. An
overview of mature miRNA annotation changes between miRBase release 9.2 and 21 is pro-
vided in S7 Table.
Supporting information
S1 Fig. miRNA binding sites. (A) Canonical 6mer, 7mer-A1, 7mer-m8 and 8mer binding site
patterns and the hierarchy in potency. (B) Canonical binding sites with 3’ supplementary bind-
ing have at least 3 contiguous pairs centered around nucleotides 13 to 16 in addition to a seed-
match. Similarly, 3’ compensatory binding involves at least 4 contiguous pairs centered around
nucleotides 12 to 17 and compensates for incomplete seed-matches or G:U wobbles. (C)Offset
6mer sites match nucleotides 3 to 8 of the 5’ end of the miRNA. (D) Seed-mismatched or G:U
wobble sites have a mismatch that can occur at any position within the seed region. (E)G-bulge
sites bulge out a guanosine between the nucleotides across positions 5 and 6 of the miRNA in
order to match the miRNA seed region. Adapted and reprinted from Van Peer et al. [37] under
a CC-BY 4.0 license, with permission from Oxford University Press, original copyright 2016.
(TIFF)
S2 Fig. Z-scores versus interaction scores. (A) Boxplot distributions of z-scores for each
miRNA, with ordering along the x-axis according to increasing median z-score. (B) Boxplot
distributions of interaction scores for each miRNA.
(TIFF)
S3 Fig. Cancer gene-miRNA interactomes. The miRNA interactomes of (A) ALK, (B)
BRCA1, (C) BRCA2, (D) EZH2, (E) FBXW7, (F)HRAS, (G)MYB, (H)MYC, (I)MYT1L,
(J)NOTCH1, (K) PALB2, (L) PHF6, (M) PHOX2B, (N) RB1 and (O) ZEB2.
(TIFF)
S1 Table. PMIDs cancer gene selection. PubMed IDs (PMIDs) of publications describing the
involvement of the cancer genes under study in different cancer entities.
(XLSX)
S2 Table. 3’ UTR reporter and RT-qPCR screening results. Results for all 7990 miRNA-3’
UTR combinations probed in replicate 3’ UTR reporter and RT-qPCR screenings. For each
cancer gene under study, the identified miRNA interactome is listed.
(XLSX)
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S3 Table. PMIDs established interactions. PubMed IDs (PMIDs) of publications describing
established miRNA interactions for the cancer genes under study.
(XLSX)
S4 Table. Site-directed mutagenesis primers. Primer sequences for site-directed mutagenesis
of canonical binding sites in 3’ UTR reporter constructs for the cancer genes under study.
(XLSX)
S5 Table. RT-qPCR primers. Forward and reverse primer sequences for reference genes and
the cancer genes under study in the RT-qPCR screening.
(XLSX)
S6 Table. Predicted miRNA-3’ UTR interactions.Overview of predicted miRNA-3’ UTR
interactions in the interactome data set.
(XLSX)
S7 Table. miRBase release comparison.Overview of mature miRNA annotation changes
between miRBase release 9.2 and 21.
(XLSX)
S1 File. miRNA sequences. FASTA file containing miRNA sequences annotated in miRBase
9.2 (except for hsa-miR-122a). Sequence identifiers contain the mature miRNA accession
number and name.
(TXT)
S2 File. 3’ UTR reporter vector map.Modified pGL4.11[luc2P] 3’ UTR reporter vector
sequence map, with indication of all functional elements.
(TXT)
S3 File. 3’ UTR sequences. FASTA file with 3’ UTR sequences for the cancer genes under
study, cloned in the modified pGL4.11[luc2P] reporter vector.
(TXT)
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